Monensin T1033L
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Monensin is an antiprotozoal agent produced by Streptomyces cinnamonensis. It has an inhibitory effect on the Wnt/_-catenin signaling cascade. Monensin is a prospective anticancer drug for the therapy of neoplasia with deregulated Wnt signaling.
CAS nr:
17090-79-8
Purity:
98%
Molecular Weight:
670,88
SMILES:
O=C(O)C(C)C(OC)C(C)C(C(C)C(O)C1)OC21CCC(C)(C3OC(C4OC(C5C(C)CC(C)C(CO)(O)O5)CC4C)(CC)CC3)O2
Formula:
C36H62O11
Pathway:
Target:
